PsyPost
  • Mental Health
  • Social Psychology
  • Cognitive Science
  • Neuroscience
  • About
No Result
View All Result
Join
My Account
PsyPost
No Result
View All Result
Home Exclusive Psychopharmacology

A single dose of 5-MeO-DMT produces rapid and persistent improvements in life satisfaction and psychopathological symptoms

by Eric W. Dolan
September 18, 2019
Reading Time: 3 mins read
(Photo credit: BurningMax)

(Photo credit: BurningMax)

Share on TwitterShare on Facebook

A single inhalation of the psychedelic drug 5-methoxy-N,N-dimethyltryptamine (5-MeO-DMT) is associated with sustained improvements in satisfaction with life, mindfulness, and a reduction of psychopathological symptoms, according to preliminary research published in Psychopharmacology.

“5-MeO-DMT is a lesser known psychedelic compared to, for example, ayahuasca and psilocybin — and thus very limited research exists,” explained study author Malin Uthaug (@malin.uthaug), a PhD candidate at Maastricht University in the Netherlands.

5-MeO-DMT occurs naturally in the venom of some toads and in a variety of plants species. It can also be produced synthetically.

“Essentially, I saw this as a niche area, and brought it upon myself to investigate its effect and therapeutic potential further as part of my doctorate work at Maastricht University. This specific article summarizes the first study I did on the topic, but there are more to come,” Uthaug said.

In the study, 42 participants completed a battery of psychology tests before inhaling vapor from dried toad secretion containing 5-MeO-DMT. The participants completed the tests again about 24 hours later and 24 participants completed the tests yet again at a 4-week follow-up assessment.

“This study was a so-called ‘naturalistic observational study.’ This means that as a researcher, I simply observed what was occurring at sessions where toad secretion containing 5-MeO-DMT was administered to participants by facilitators, and distributed questionnaires to the participants,” Uthaug explained.

“Although there are limitations with this design (no placebo-control, participant bias, etc), it has an advantage in the sense that it allows researchers to get a better look at drug effects than what the current legality status of psychedelics permit.”

The researchers found that subjective ratings of life satisfaction, depression, anxiety, and mindfulness improved on the day after the session, and this effect persisted for four weeks. The findings are in line with a previous survey of 362 adults, which found that approximately 80& of respondents reported improvements in anxiety and depression after using 5-MeO-DMT.

Google News Preferences Add PsyPost to your preferred sources

But there also does not appear to be anything particularly special about toad venom compared to synthetic 5-MeO-DMT.

“Another important take-away from the study is that 5-MeO-DMT is the main compound in the toad secretion as demonstrated by our lab-analysis,” Uthaug said.

“This finding, as well as the outlined ethical and ecological consideration of toad secretion use, make a clear and strong argument for the discontinuation of toad secretion as a means of obtaining and consuming 5-MeO-DMT. In other words, ‘save a toad – exploit a chemist.‘”

Previous research has indicated that 5-MeO-DMT has a relatively safe profile of use and is predominantly used for spiritual exploration. But there is still much to learn about the psychedelic drug.

“The results of the present study are in no way conclusive, and more research is warranted to investigate 5-MeO-DMT further. The rest of our studies on 5-MeO-DMT (from my dissertation as well as other collaborations) are yet to be published, and include one study outlining the effects of 5-MeO-DMT on biomarkers (salivary cortisol and IL-6), and another comparing the effects and experiences following vaporization or intramuscular injection,” Uthaug told PsyPost.

“These will all amplify the current literature, but future clinical research and safety assessment of 5-MeO-DMT, specifically through the intramuscular route, is highly warranted before a clinical trial can commence.”

Uthaug also noted that some facilitators of 5-MeO-DMT face serious allegations of malpractice.

“Additionally, none of the facilitators have the necessary expertise (clinical background) to properly hold a safe space where altered states of consciousness can be entered, nor to screen for contraindications in participants that are included in a session,” she said. “This is dangerous as it puts people at unnecessary risk for having an unpleasant and even traumatic experience, which can impact them as well as those around them negatively.”

The study, “A single inhalation of vapor from dried toad secretion containing 5-methoxy-N,N-dimethyltryptamine (5-MeO-DMT) in a naturalistic setting is related to sustained enhancement of satisfaction with life, mindfulness-related capacities, and a decrement of psychopathological symptoms“, was authored by M. V. Uthaug, R. Lancelotta, K. van Oorsouw, K. P. C. Kuypers, N. Mason, J. RakA. Šuláková, R. Jurok, M. Maryška, M. Kuchař, T. Páleníček, J. Riba, and J. G. Ramaekers.

RELATED

New research sheds light on cannabinoids’ impact on anxiety during alcohol withdrawal
Addiction

Lesser-known cannabis compounds show promise for treating alcohol addiction in rats

May 31, 2026
New psychology research flips the script on happiness and self-control
Cannabis

How a dose of medicinal cannabis alters brain waves during sleep

May 30, 2026
New study projects a massive shortage of adult psychiatrists in the United States
Depression

Clinical trial suggests an anti-inflammatory drug could relieve difficult-to-treat depression

May 27, 2026
What 50 years of data say about the happiness of single parents
Ketamine

Low-dose ketamine shows promise for easing chronic fatigue

May 24, 2026
Negative emotions tied to sexual experiences take longer to fade than everyday memories
Psychedelic Drugs

How sharing a psychedelic experience changes romantic relationships

May 19, 2026
Negative emotions tied to sexual experiences take longer to fade than everyday memories
Depression

Brain connectivity predicts how well antidepressants work compared to placebos

May 19, 2026
Negative emotions tied to sexual experiences take longer to fade than everyday memories
Addiction

A healthy diet doesn’t cancel out the inflammatory effects of alcohol, study finds

May 19, 2026
Negative emotions tied to sexual experiences take longer to fade than everyday memories
Neuroimaging

Brain scans reveal how ibogaine alters neural networks in veterans with head trauma

May 19, 2026

Follow PsyPost

The latest research, however you prefer to read it.

Daily newsletter

One email a day. The newest research, nothing else.

Google News

Get PsyPost stories in your Google News feed.

Add PsyPost to Google News
RSS feed

Use your favorite reader. We also syndicate to Apple News.

Copy RSS URL
Social media
Support independent science journalism

Ad-free reading, full archives, and weekly deep dives for members.

Become a member

Trending

  • More than half of adults with ADHD in clinical settings have a co-occurring personality disorder
  • New study links parental indulgence to psychopathic and narcissistic traits in adulthood
  • How learning to read alters the brain’s approach to spoken language
  • The psychology of paradoxical thinking: Extreme arguments in favor of a controversial topic can reduce overall support
  • Men’s sexual desire peaks around age 40, large new study finds

Science of Money

  • Class isn’t dead: Your job title still predicts your wealth in Europe, a five-country study finds
  • Packing products tightly on shelves makes shoppers grab more flavors
  • When your job feels scriptable: How routine work and AI anxiety drain employee energy
  • Childhood obesity and the American Dream: New research links early weight to lower lifetime mobility
  • The brain chemical behind your money moves: How dopamine shapes financial choices

PsyPost is a psychology and neuroscience news website dedicated to reporting the latest research on human behavior, cognition, and society. (READ MORE...)

  • Mental Health
  • Neuroimaging
  • Personality Psychology
  • Social Psychology
  • Artificial Intelligence
  • Cognitive Science
  • Psychopharmacology
  • Contact us
  • Disclaimer
  • Privacy policy
  • Terms and conditions
  • Do not sell my personal information

(c) PsyPost Media Inc

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In

Add New Playlist

Subscribe
  • My Account
  • Cognitive Science Research
  • Mental Health Research
  • Social Psychology Research
  • Drug Research
  • Relationship Research
  • About PsyPost
  • Contact
  • Privacy Policy

(c) PsyPost Media Inc